Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| JAKKS PACIFIC INC | 174,246 | reported | 09 Aug 2019 | tx 8+173,151−27,352 |
| Nant Health, LLC | 100,000 | reported | 16 Jun 2021 | tx 6+650,688 |
| Abraxis Biosciences, Inc. | 0 | reported | 15 Oct 2010 | tx 2+10,000−10,000 |
| AMERICAN PHARMACEUTICAL PARTNERS INC /DE/ | 0 | reported | 10 Sept 2008 | tx 4+17,500−24,649 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Jun 2021 | GRANT_AWARD | Nant Health, LLC | 100,000 | 0.00 USD | deriv |
| 21 May 2020 | GRANT_AWARD | Nant Health, LLC | 100,000 | 0.00 USD | deriv |
| 09 Aug 2019 | OTHER | JAKKS PACIFIC INC | 13,676 | 1.83 USD | |
| 13 Jun 2019 | GRANT_AWARD | Nant Health, LLC | 301,908 | 0.00 USD | deriv |
| 01 Jan 2019 | GRANT_AWARD | JAKKS PACIFIC INC | 54,705 | 1.83 USD | |
| 06 Sept 2018 | GRANT_AWARD | Nant Health, LLC | 45,002 | 0.00 USD | |
| 06 Sept 2018 | GRANT_AWARD | Nant Health, LLC | 52,910 | 0.00 USD | |
| 01 Jan 2018 | GRANT_AWARD | JAKKS PACIFIC INC | 41,580 | 2.41 USD | |
| 06 Nov 2017 | GRANT_AWARD | Nant Health, LLC | 50,868 | 0.00 USD | |
| 07 Aug 2017 | PURCHASE | JAKKS PACIFIC INC | 10,000 | 3.50 USD | first after silence |
| 01 Jan 2017 | GRANT_AWARD | JAKKS PACIFIC INC | 19,324 | 5.17 USD | |
| 26 Feb 2016 | PURCHASE | JAKKS PACIFIC INC | 35,000 | 6.75 USD | |
| 01 Jan 2016 | GRANT_AWARD | JAKKS PACIFIC INC | 12,542 | 7.97 USD | |
| 15 Oct 2010 | OTHER | Abraxis Biosciences, Inc. | 10,000 | 35.06 USD | deriv |
| 10 Dec 2009 | GRANT_AWARD | Abraxis Biosciences, Inc. | 10,000 | 0.00 USD | deriv |
| 10 Sept 2008 | OTHER | AMERICAN PHARMACEUTICAL PARTNERS INC /DE/ | 10,000 | 10.28 USD | deriv |
| 10 Sept 2008 | OTHER | AMERICAN PHARMACEUTICAL PARTNERS INC /DE/ | 14,649 | 10.27 USD | deriv |
| 19 Dec 2007 | GRANT_AWARD | AMERICAN PHARMACEUTICAL PARTNERS INC /DE/ | 10,000 | 10.28 USD | deriv |
| 01 Aug 2006 | GRANT_AWARD | AMERICAN PHARMACEUTICAL PARTNERS INC /DE/ | 7,500 | 20.07 USD |
1 purchase reported after at least 12 months of silence — most recent on 07 Aug 2017.